{
    "nct_id": "NCT04457232",
    "official_title": "PET Biodistribution Study of 68Ga-FAPI-46 in Patients With Prostate Cancer: A Prospective Exploratory Biodistribution Study With Histopathology Validation",
    "inclusion_criteria": "* Patients who underwent a 68Ga-PSMA-11 PET/CT scan within 3 months of enrollment\n* Patients who are scheduled to undergo surgical excision or biopsy of a prostate cancer primary, recurrent or metastatic lesion\n* Patients can provide written informed consent\n* Patients are able to remain still for duration of imaging procedure (up to one hour)\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients with any new prostate therapy between the PSMA PET/CT and the FAP inhibitor (FAPI) PET/CT",
    "miscellaneous_criteria": ""
}